Gastrointestinal Radiofrequency Ablation Systems Market Players:
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ATRICURE, INC.
- Royal Philips
- Boston Scientific Corporation
- Johnson & Johnson
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of gastrointestinal radiofrequency ablation systems is evaluated at USD 4.83 billion.
The global gastrointestinal radiofrequency ablation systems market size was worth over USD 4.54 billion in 2025 and is poised to grow at a CAGR of around 7.1%, reaching USD 9.01 billion revenue by 2035.
North America is anticipated to capture a 35% share of the Gastrointestinal Radiofrequency Ablation Systems Market by 2035, stemming from the increasing incidence of stomach cancer.
Key players in the market include ATRICURE, INC, Royal Philips, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Japan Lifeline Co. Ltd, Medtronic Japan Co. Ltd, Olympus Corporation, Astellas Pharma Inc.
